Abstract
Background Evaluation of serological assays for hepatitis C (HCV) antibody screening is crucial ,as supplemental testing [Nucleic Acid Testing & Recombinant Immunoblot Assay (RIBA)] to verify anti-HCV reactive results is not widely practiced, due to limited availability and high cost. The current study was undertaken from January to May 2011, to evaluate 4 serological assays for HCV diagnosis, viz-a-viz HCV RNA PCR and RIBA.
Highlights
Evaluation of serological assays for hepatitis C (HCV) antibody screening is crucial,as supplemental testing [Nucleic Acid Testing & Recombinant Immunoblot Assay (RIBA)] to verify anti-HCV reactive results is not widely practiced, due to limited availability and high cost
Comparative evaluation of screening and supplementary assays used in HCV diagnosis Vidya Nerurkar*, Prabhupad Rath, Rashmi Khadapkar, Simi Bhatia, Bibhu Ranjan Das
The current study was undertaken from January to May 2011, to evaluate 4 serological assays for HCV diagnosis, viz-a-viz HCV RNA PCR and RIBA
Summary
Comparative evaluation of screening and supplementary assays used in HCV diagnosis Vidya Nerurkar*, Prabhupad Rath, Rashmi Khadapkar, Simi Bhatia, Bibhu Ranjan Das. From First International Science Symposium on HIV and Infectious Diseases (HIV SCIENCE 2012) Chennai, India. 20-22 January 2012
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
